Mumbai, Sept. 25 -- Securities in F&O Ban:

RBL Bank, Sammaan Capital and HFCL are banned from futures and options (F&O) trading on 25 September 2025.

Stocks to Watch:

Glenmark Pharmaceuticals announced that its arm, Glenmark Specialty, entered into an exclusive licensing agreement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811), a HER2-targeting antibody drug conjugate.

Newgen Software Technologies said that its arm signed a five-year Master Service Agreement with Tata Consultancy Services N.V., valued at €4.22 million (around Rs 44 crore).

Lupin announced that it has received tentative approval from the USFDA for Bictegravir, Emtricitabine & Tenofovir Alafenamide Tablets, used for treating human immunodeficiency viru...